InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: noretreat post# 1678

Thursday, 09/26/2019 3:29:55 PM

Thursday, September 26, 2019 3:29:55 PM

Post# of 3892
I actually liked clean update.

- Most likely approval in one month for a new SOC drug for large population.
This itself is big very near term catalyst

- one pivotal phase 3 study to start within 3 months

- one FDA meeting on potential path to approval. Successful P3 completed

- one registration phase 3 study under preparation

- one cancer drug P2 in preparation

Not a bad portfolio for a small company. They have field force so if Talicia is approved their overhead gets distributed over new drug.

I am in very much red but like the company and chances to go into green
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News